Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Buprenorphine 74.2mg implant |
| BNF code | 0410030A0AAAWAW |
| Virtual Therapeutic Moiety | Buprenorphine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 5 Dec 2025 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | device |
| Unit dose unit of measure | device |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Buprenorphine hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 387173000 |
| Strength value numerator | 74.200 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | implant.subcutaneous |
| Dose Form | |
| Formulation | Prolonged-release subcutaneous implant |
| Drug Route | |
| Route | Subcutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 3 (CD No Register) |
| Virtual Medicinal Product Packs | |
| Buprenorphine 74.2mg implant 4 device | |
dm+d data retrieved from TRUD: release NHSBSA_12.3.0_20251222000001, imported on 23rd December 2025 at 04:11:19.